Vaccine Insights

VACCINE INSIGHTS

October 2023 Issue

Vol 2 Issue 10

RNA vaccines Part 2: Addressing ongoing challenges

Featuring this month's spotlight content:

RNA vaccines Part 2: Addressing ongoing challenges
View
Vaccine Insights Vol 2 Issue 10
View

Latest Articles

Streamlining vaccine development & production with modality-specific purification tools for mRNA & beyond

Streamlining vaccine development & production with modality-specific purification tools for mRNA & beyond

Eugene Sun
22 November
Innovator Insight
Optimizing CMC to make vaccines for the world

Optimizing CMC to make vaccines for the world

Piper Trelstad
22 November
Interview
Establishing self-sustaining vaccine manufacturing ecosystems: Africa’s priority diseases

Establishing self-sustaining vaccine manufacturing ecosystems: Africa’s priority diseases

N Ndembi, N Ngongo, M Kifle Habtemariam et al.
22 November
Nonclinical development of RNA cancer vaccines: proof-of-concept testing, safety study design, and future prospects

Nonclinical development of RNA cancer vaccines: proof-of-concept testing, safety study design, and future prospects

Rondine Allen, Christopher Saeui
9 November
Regulatory perspective
Developing an effective vaccine formulation using self-amplifying RNA and a nanoparticle emulsion

Developing an effective vaccine formulation using self-amplifying RNA and a nanoparticle emulsion

Amit Khandhar
8 November
Interview
Optimizing in vitro transcription reactions: from fundamental research to mRNA vaccine manufacturing

Optimizing in vitro transcription reactions: from fundamental research to mRNA vaccine manufacturing

Craig Martin
8 November
Interview
mRNA fragmentation and quality assessment using ion pair reverse-phase analytics

mRNA fragmentation and quality assessment using ion pair reverse-phase analytics

A Ferjančič Budihna, A Martinčič Celjar, S Lebar et al.
1 November
Innovator Insight
Risk-based approach to leverage prior knowledge & statistical modeling during process development & process characterization of multivalent vaccines

Risk-based approach to leverage prior knowledge & statistical modeling during process development & process characterization of multivalent vaccines

B Carrillo Conde, E Rainbolt, A Cheng et al.
25 October
Expert Insight
Physical methods to overcome tissue barriers in vaccine delivery

Physical methods to overcome tissue barriers in vaccine delivery

T Ahmed, D Freitas, X Huang et al.
25 October
Review